08 Cervical Cancer Clinical

(1)

CERVICAL CANCER Clinical

1. Mohd Rushdan MN. Current status and future direction of cervical cancer prevention program in Malaysia. 2008;.

2. Gita J, Razak A. Villoglandular adenocarcinoma of cervix--a tumour with bland cytological features: report of a case missed on cytology. Malays J Pathol 2003;25(2):139-143

http://www.mjpath.org.my/past_issue/MJP2003.2/07Case%20Report(Villoglandular).pdf.

3. Looi M, Ahmad Zailani Hatta, Mohd Dali, Siti Aishah MA, et al. Expression of p16 and pKi-67 in cervical preneoplasia and neoplasia. Asia-Pacific Journal of Molecular Medicine 2011;1:1-7

http://journalarticle.ukm.my/3058/1/2011-1-6.pdf.

4. Cheah PL, Looi LM. Significance of Bcl-2 and Bax proteins in cervical carcinogenesis: an immunohistochemical study in squamous cell carcinoma and squamous intraepithelial lesions. Malays J Pathol 2006;28(1):1-5

http://www.mjpath.org.my/past_issue/MJP2006.1/01-Bcl-2.pdf.

5. Cheah PL, Looi LM, Mun KS, et al. Implications of continued upregulation of p16(INK4a) through the evolution from high-grade squamous intraepithelial lesion to invasive squamous carcinoma of the cervix. Malays J Pathol 2011;33(2):83-87

http://www.mjpath.org.my/2011.2/p16.pdf.

6. Mat-Isa NA, Mashor MY, Othman NH. An automated cervical pre-cancerous diagnostic system. Artif Intell Med 2008;42(1):1-11.

7. Wong LP. Preventing cervical cancer through human papillomavirus vaccination: perspective from focus groups. J Low Genit Tract Dis 2009;13(2):85-93.

8. El-Tawil SG, Adnan R, Muhamed ZN, et al. Comparative study between Pap smear cytology and FTIR spectroscopy: a new tool for screening for cervical cancer. Pathology 2008;40(6):600-603.

9. Woo YL, Omar SZ. Human papillomavirus vaccination in the resourced and resource-constrained world. Best Pract Res Clin Obstet Gynaecol 2011;25(5):597-603.

(2)

11. Wong YL, Chinna K, Mariapun J, et al. Correlates between risk perceptions of cervical cancer and screening practice. Prev Med 2013;57 Suppl:S24-6.

12. Woo YL, Badley C, Jackson E, et al. Long-term cytological and histological outcomes in women managed with loop excision treatment under local anaesthetic for high-grade cervical intraepithelial neoplasia. Cytopathology 2011;22(5):334-339.

13. Looi ML, Karsani SA, Rahman MA, et al. Plasma proteome analysis of cervical intraepithelial neoplasia and cervical squamous cell carcinoma. J Biosci 2009;34(6):917-925.

14. Cheah PL, Looi LM. P53 immunohistochemical expression: messages in cervical carcinogenesis. Pathology 2002;34(4):326-331.

15. Tan GC, Isa MR, Ng SP, et al. Unusual form of superficial spreading microinvasive squamous cell carcinoma of uterine cervix involving the endometrium of uterus. J Obstet Gynaecol Res 2004;30(5):363-367.

16. Dunn RA, Tan AK. Cervical cancer screening in Malaysia: Are targeted interventions necessary? Soc Sci Med 2010;71(6):1089-1093.

17. Looi ML, Dali AZ, Ali SA, et al. Expression of p53, bcl-2 and Ki-67 in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix. Anal Quant Cytol Histol 2008;30(2):63-70.

18. Nor Hayati O. Cancer of the cervix - from bleak past to bright future; a review, with an emphasis on cancer of the cervix in malaysia. Malays J Med Sci 2003;10(1):13-26

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557105/pdf/mjms-10-1-013.pdf.

19. Nor Hayati O. Cervical cancer - understanding its molecular genesis and proposing the use of molecular pap smear in Malaysia. Genetik 2004;10(2):1

http://www.persatuangenetikmalaysia.com/bulletindec04.pdf.

20. Sivanesaratnam V. Management of the pregnant mother with malignant conditions. Curr Opin Obstet Gynecol 2001;13(2):121-125.

21. Lokamani I, Looi ML, Ali SA, et al. Clusterin as a potential marker in distinguishing cervical neoplasia. Anal Quant Cytol Histol 2011;33(4):223-228.

22. Al-Naggar RA, Low WY, Zaleha MI. Knowledge and barriers towards cervical cancer screening among young women in Malaysia. Asian Pac J Cancer Prev 2010;11(4):867-873

(3)

23. Tan YY, Hesham R, Qodriyah HM. Knowledge and attitude of university students in health sciences on the prevention of cervical cancer. Med J Malaysia 2010;65(1):53-57

http://www.e-mjm.org/2010/v65n1/Cervical_cancer.pdf.

24. Tran NT, Choe SI, Taylor R, et al. Knowledge, attitude and practice (KAP) concerning cervical cancer and screening among rural and urban women in six provinces of the Democratic People's Republic of Korea. Asian Pac J Cancer Prev 2011;12(11):3029-3033.

25. Looi ML, Mohd Dali AZ, Md Ali SA, et al. Oxidative damage and antioxidant status in patients with cervical intraepithelial neoplasia and carcinoma of the cervix. Eur J Cancer Prev 2008;17(6):555-560.

26. Abdul-Rahman PS, Lim BK, Hashim OH. Expression of high-abundance proteins in sera of patients with endometrial and cervical cancers: analysis using 2-DE with silver staining and lectin detection methods. Electrophoresis 2007;28(12):1989-1996.

27. Sudirman A, Sukumar N, Davaraj B. Appendicular metastasis from carcinoma cervix. Med J Malaysia 2001;56(1):100-101

http://www.e-mjm.org/2001/v56n1/Carcinoma_Cervix.pdf.

28. Wong LP, Wong YL, Low WY, et al. Knowledge and awareness of cervical cancer and screening among Malaysian women who have never had a Pap smear: a qualitative study. Singapore Med J 2009;50(1):49-53

http://smj.sma.org.sg/5001/5001a6.pdf.

29. Hayati AR, Zulkarnaen M. An immunohistochemical study of CD1a and CD83-positive infiltrating dendritic cell density in cervical neoplasia. Int J Gynecol Pathol 2007;26(1):83-88.

30. Abu Backer FM, Mustapha NR, Othman NH. Combined expression of p161NK4a and p27Kip1, but not p21WAF1, differentiates endocervical from endometrial adenocarcinoma. Anal Quant Cytol Histol 2011;33(5):283-288.

31. Afzan MY, Suresh K. Pseudocyst forms of Trichomonas vaginalis from cervical neoplasia. Parasitol Res 2012;111(1):371-381.

32. Yusof AM, Kumar S. Phenotypic 'variant' forms of Trichomonas vaginalis trophozoites from cervical neoplasia patients. Exp Parasitol 2012;131(3):267-273.

33. Lee MY, Telisinghe PU, Ramasamy R. Cervical cancer in Brunei Darussalam. Singapore Med J 2012;53(9):604-607

(4)

34. Wong LP, Sam I-. Current issues facing the introduction of human papillomavirus vaccine in Malaysia. Malaysian Family Physician 2007;2(2):47-53

http://www.scopus.com/inward/record.url?eid=2-s2.0-43049118267&partnerID=40&md5=1d9130dae890050b6ffb2a851f87a9e5.

35. Al-Dubai SAR, Alshagga MA, Al-Naggar RA, et al. Knowledge, attitudes and barriers for human papilloma virus (HPV) vaccines among Malaysian women. Asian Pac J Cancer Prev 2010;11(4):887-892

http://www.apocp.org/cancer_download/Volume11_No4/c%20887-92%20%20Al-Dubai.pdf.

36. Sivalingam N. Clinical Practice Guidelines on Management of Cervical Cancer. 2003;.

37. Fauzi AN, Norazmi MN, Yaacob NS. Tualang honey induces apoptosis and disrupts the mitochondrial membrane potential of human breast and cervical cancer cell lines. Food Chem Toxicol 2011;49(4):871-878.

38. Ng WK, Yazan LS, Ismail M. Thymoquinone from Nigella sativa was more potent than cisplatin in eliminating of SiHa cells via apoptosis with down-regulation of Bcl-2 protein. Toxicol In Vitro 2011;25(7):1392-1398.

39. Abdelwahab SI, Abdul AB, Zain ZN, et al. Zerumbone inhibits interleukin-6 and induces apoptosis and cell cycle arrest in ovarian and cervical cancer cells. Int Immunopharmacol 2012;12(4):594-602.

40. Abdelwahab SI, Abdul AB, Devi N, et al. Regression of cervical intraepithelial neoplasia by zerumbone in female Balb/c mice prenatally exposed to diethylstilboestrol: involvement of mitochondria-regulated apoptosis. Exp Toxicol Pathol 2010;62(5):461-469.

41. Nieuwenhuizen L, Khalil MK, Venkatesh N, et al. Endometrial and endocervical secretion: the search for histochemical differentiation. Anal Quant Cytol Histol 2006;28(2):87-96.

42. Devi BC, Tang TS, Corbex M. Reducing by half the percentage of late-stage presentation for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in Sarawak, Malaysia. Ann Oncol 2007;18(7):1172-1176.

43. Marjmin O, Badrulhisham B, Teoh CM, et al. Metastatic cervical carcinoma in the caecum. Med J Malaysia 2005;60(1):97-98

http://www.e-mjm.org/2005/v60n1/Metastatic_Cervical_Carcinoma.pdf.

(5)

following radical surgery based on the GOG score--a pilot study. Ann Acad Med Singapore 2004;33(4):467-472.

45. Asma A, Maizaton AA. Kimura's disease: an unusual cause of cervical tumor. Med J Malaysia 2005;60(3):373-376

http://www.e-mjm.org/2005/v60n3/Kimuras_Disease.pdf.

46. Ab Hamid S, Wastie ML. Primary non-Hodgkin's lymphoma presenting as a uterine cervical mass. Singapore Med J 2008;49(3):e73-5

http://smj.sma.org.sg/4903/4903cr4.pdf.

47. Shanthi V, Majdah M, Syed Aljunid, et al. Cervical cancer in Malaysia: can we improve our screening and preventive practice? BMC Public Health 2012;12(Suppl 2):A17

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507984/pdf/1471-2458-12-S2-A17.pdf.

48. Sharifa Ezat WP, Aljunid SM, Ng P, et al. Quality of life among preinvasive and invasive cervical cancer in Malaysia. ASEAN Journal of Psychiatry 2009;10(2):115-126

http://www.aseanjournalofpsychiatry.org/pdf/2ASEAN_3_Ezat.pdf.

49. Devi Beena CR, Tang TS, Gerard LC. Preliminary results from the pilot study on the National Cancer Patient Registry--Cervical Cancer. Med J Malaysia 2008;63 Suppl C:63-65

50. Norodiyah O, Othman NH. Adequacy of cellular material in split-sampling of cervical scrapings for routine cancer screening: an analysis of 702 smears. Malays J Pathol 2012;34(2):115-121

http://www.mjpath.org.my/2012.2/cancer-screening.pdf.

51. Saini R, Shen TH, Othman NH, et al. Evaluation of polymerase chain reaction (PCR) method and hybrid capture II (HCII) assay for the detection of human papillomavirus in cervical scrapings. Med J Malaysia 2007;62(3):206-209

http://www.e-mjm.org/2007/v62n3/Human_Papillomavirus.pdf.

52. Tran NT, Taylor R, Choe SI, et al. Knowledge, attitude and practice (KAP) concerning cervical cancer and screening among rural and urban female healthcare practitioners in the Democratic People's Republic of Korea. Asian Pac J Cancer Prev 2011;12(11):3023-3028.

(6)

54. Chong PP, Asyikin N, Rusinahayati M, et al. High prevalence of human papillomavirus DNA detected in cervical swabs from women in southern Selangor, Malaysia. Asian Pac J Cancer Prev 2010;11(6):1645-1651

http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No6/c%201645-51%2011.03%20P%20P%20Chong.pdf.

55. Cheah PL, Looi LM, Sivanesaratnam V. Human papillomavirus in cervical cancers of Malaysians. J Obstet Gynaecol Res 2011;37(6):489-495.

56. Tay SK, Tay YK. The prevalence and significance of high-risk human papillomavirus DNA test in southern Malaysia and Singapore. Aust N Z J Obstet Gynaecol 2009;49(3):323-327.

57. Chow SN, Soon R, Park JS, et al. Knowledge, attitudes, and communication around human papillomavirus (HPV) vaccination amongst urban Asian mothers and physicians. Vaccine 2010;28(22):3809-3817.

58. Wong LP, Sam IC. Ethnically diverse female university students' knowledge and attitudes toward human papillomavirus (HPV), HPV vaccination and cervical cancer. Eur J Obstet Gynecol Reprod Biol 2010;148(1):90-95.

59. Farzaneh F, Shirvani HE, Barouti E, et al. Knowledge and attitude of women regarding the human papillomavirus (HPV) infection, its relationship to cervical cancer and prevention methods. Med J Malaysia 2011;66(5):468-473

http://www.e-mjm.org/2011/v66n5/Human_Papillomavirus.pdf.

60. Naing C, Pereira J, Abe T, et al. Predictors associated with the willingness to take human papilloma virus vaccination. J Community Health 2012;37(2):288-293.

61. Wong LP. Knowledge and attitudes about HPV infection, HPV vaccination, and cervical cancer among rural southeast Asian women. Int J Behav Med 2011;18(2):105-111.

62. Sam IC, Wong LP, Rampal S, et al. Maternal acceptance of human papillomavirus vaccine in Malaysia. J Adolesc Health 2009;44(6):610-612.

63. Wong LP. HPV information needs, educational messages and channel of delivery preferences: views from developing country with multiethnic populations. Vaccine 2009;27(9):1410-1415.

64. Domingo EJ, Noviani R, Noor MR, et al. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam. Vaccine 2008;26 Suppl 12:M71-9.

(7)

HEALTH BEHAVIOUR:

66. Nor Hayati O, Beena CD, Halimah Y. Cervical cancer screening: patients understanding in major hospitals in Malaysia. Asian Pac J Cancer Prev 2009;10(4):569-574

http://www.apocpcontrol.org/paper_file/issue_abs/Volume10_No4/c %20569%20Othman.pdf.

67. Rima Marhayu AR, Majdah M, Zaleha AH, et al. Is the phone call the most effective method for recall in cervical cancer screening? - results from a randomised control trial. Asian Pac J Cancer Prev 2013;14(10):5901-5904

http://www.ncbi.nlm.nih.gov/pubmed/24289597

68. Rima Marhayu AR, Maznah D. Study protocol for the most effective recall method in a cervical cancer screening program in Klang, Malaysia. Asian Pac J Cancer Prev 2013;14(10):5867-5870

http://www.ncbi.nlm.nih.gov/pubmed/24289591

69. Rima Marhayu AR, Maznah D, Majdah M, et al. Adapting the Australian system: is an organized screening program feasible in Malaysia?--an overview of cervical cancer screening in both countries. Asian Pac J Cancer Prev 2013;14(3):2141-2146

http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No3/2141-2146%202.5%20Rima%20Marhayu%20Abdul%20Rashid_1.pdf.

70. Al-Naggar RA, Al-Jashamy K, Chen R. Perceptions and opinions regarding human papilloma virus vaccination among young women in Malaysia. Asian Pac J Cancer Prev 2010;11(6):1515-1521

http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No6/c%201515-21%2010.21%20Redhwan%20Ahmed%20Al-Naggar.pdf.

71. Farveen Marican AB, Nik Raihan NM, Nor Hayati O. Clinicopathological comparison of adenocarcinoma of cervix and endometrium using cell cycle markers: P16ink4a, P21waf1, and p27Kip1 on 132 cancers. Infect Dis Obstet Gynecol 2011;2011:857851

http://web.ebscohost.com.ezp.imu.edu.my/ehost/pdfviewer/pdfviewer?sid=71afbef8-5f1c-44f2-9fd8-5931a898c0b7%40sessionmgr4003&vid=4&hid=4112.

(8)

http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No2/825-28%201.15%20Nuradhiathy%20Abd%20Razak.pdf.

73. Woo YL, Sharina MR, Chong KR, et al. Does the success of a school-based HPV vaccine programme depend on teachers' knowledge and religion? -- A survey in a multicultural society. Asian Pac J Cancer Prev 2012;13(9):4651-4654

http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No9/4651-54%208.13%20Yin %20Ling%20Woo.pdf.

74. Al-Naggar RA, Bobryshev YV, Al-Jashamy K, et al. Practice of HPV vaccine and associated factors among school girls in Melaka, Malaysia. Asian Pac J Cancer Prev 2012;13(8):3835-3840

http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No8/3835-40%205.7%20Redhwan%20Ahmed%20Al-Naggar%20%28girls%20in%20Malaka%29.pdf.

HEALTH BEHAVIOUR:

75. Hesham HR, Nur Zakiah, N Mohd Saat, Dahlia Nadira AM. Knowledge, attitude and practice of malaysian medical and pharmacy students towards human papillomavirus vaccination. Asian Pac J Cancer Prev 2012;13(5):2279-2283

http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No5/2279-83%2010.6%20Hesham%20H%20Rashwan.pdf.

76. Al-Naggar RA, Bobryshev YV. Practice towards human papillomavirus vaccines among Malaysian women: a survey of a general youth population. Asian Pac J Cancer Prev 2011;12(8):2045-2049

http://www.apocpcontrol.org/paper_file/issue_abs/Volume12_No8/2045-49%20c7.30%20Al-Naggar.pdf.

77. Hesham R, Syarif Husin L, Kiat AN. Knowledge of cervical cancer and acceptance of HPV vaccination among secondary school students in Sarawak, Malaysia. Asian Pac J Cancer Prev 2011;12(7):1837-1841

http://www.apocpcontrol.org/paper_file/issue_abs/Volume12_No7/1837-1841%20c %206.27%20Hesham%20Rashwan.pdf

(9)

http://www.apocpcontrol.org/paper_file/issue_abs/Volume12_No6/1429-1433%20c %205.11%20Chung%20Lee%20Khoo.pdf.

79. Fauziah A, Norlaili AA, Su TT. Factors related to poor practice of Pap smear screening among secondary school teachers in Malaysia. Asian Pac J Cancer Prev 2011;12(5):1347-1352

http://www.apocpcontrol.org/paper_file/issue_abs/Volume12_No5/1347-1352%20c %204.17%20Fauziah%20Abdullah.pdf.

80. Syed M Aljunid, Zafar A, Saperi S, et al. Burden of disease associated with cervical cancer in Malaysia and potential costs and consequences of HPV vaccination. Asian Pac J Cancer Prev 2010;11(6):1551-1559

www.apocpcontrol.org/paper_file/issue_abs/Volume11_No6/c 1551-59 10.25 S Aljunid.pdf.

81. Fauziah A, Su TT. Enhancement of the cervical cancer screening program in Malaysia: a qualitative study. Asian Pac J Cancer Prev 2010;11(5):1359-1366

http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No5/c%201359-66%20Fauziah %20Abdullah.pdf.

82. Sharifa Ezat WP, Syed Aljunid. Cost-effectiveness of HPV vaccination in the prevention of cervical cancer in Malaysia. Asian Pac J Cancer Prev 2010;11(1):79-90

http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No1/79%20c%20Sharif %20Ezat.pdf.

83. Sharifa Ezat WP, Syed Aljunid. Comparative cost-effectiveness of HPV vaccines in the prevention of cervical cancer in Malaysia. Asian Pac J Cancer Prev 2010;11(4):943-951

http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No4/c%20943-51%20Ezat.pdf.

84. Sharifa Ezat WP, Rozita H, Jamsiah M, et al. National HPV immunisation programme: knowledge and acceptance of mothers attending an obstetrics clinic at a teaching hospital, Kuala Lumpur. Asian Pac J Cancer Prev 2013;14(5):2991-2999

http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No5/2991-99%204.8%20Sharifa%20Ezat%20.pdf

(10)

http://www.apocpcontrol.org/paper_file/issue_abs/Volume10_No5/747%20c%20Nor %20Hayati%20.pdf.

86. Sharifah Noor Akmal, Seeni A, Nurismah M, et al. Prevalence of human papillomavirus in abnormal cervical smears in Malaysian patients. Asian Pac J Cancer Prev 2009;10(2):303-306.

87. Sharifa Ezat WP, Sharifah NA, Sayyidi Hamzi A, et al. Prevalence of human papillomavirus genotypes in preinvasive and invasive cervical cancer-A UKM study. Med Health 2010;5(2):66-76

http://journalarticle.ukm.my/2071/1/06-MS_084_-_proof__66-76_.pdf.

88. Tan GC, Sharifah Noor Akmal, Shiran MS, et al. Utility of Ki-67 and p53 in distinguishing cervical intraepithelial neoplasia 3 from squamous cell carcinoma of the cervix. Asian Pac J Cancer Prev 2008;9(4):781-784

http://www.apocpcontrol.org/paper_file/issue_abs/Volume9_No4/781%20c%20Tan.pdf.

89. Mohamad Nasir S, Nazimah I, Rushdan MN. The Role of Computed Tomography (CT) Scan in Assessment of the Parametrial Involvement in Early Stage Cervical Carcinoma. Journal of Surgical Academia 2012;2(1):14

http://journalarticle.ukm.my/5179/1/04-MS1056%2814-17%29.pdf.

90. Shafiee M, NorAzlin M, Lim P, et al. Emergency chemotherapy’ for bleeding cervical cancer: case series. Journal of Surgical Academia 2012;2(2):35

http://journalarticle.ukm.my/5942/1/09-MS1066_%2835-37%29_1.pdf.

91. Aishah AM, Osman A. Knowledge, attitude and practice among midwives and community nurses on cervical cancer in the state of Kedah in 1997. Jurnal Kesihatan Masyarakat 2006;12(1).

92. Al-Jashamy K, Al-Naggar RA, San P, et al. Histopathological findings for cervical lesions in Malaysian women. Asian Pac J Cancer Prev 2009;10(6):1159-1162

http://www.apocpcontrol.org/paper_file/issue_abs/Volume10_No6/1159_c_Al-Jashamy.pdf.

(11)

http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No10/5901-5904%207.17%20Rima%20Marhayu%20Abdul%20Rashid.pdf.

94. Sharifa Ezat WP, Norin Rahayu S, Sharifah Noor Akmal, Syed Hussain, et al. HPV Positivity and its’ Influencing factors among invasive cervical cancer women in Malaysia. International Journal of Public Health Research. International Journal of Public Health Research 2011;1(1):13

http://journalarticle.ukm.my/3340/1/vol%25201%2520no%25201%25202011_3.pdf.

95. Ahmad Bustamam A, Abdelwahab SI, Johari J, et al. Combination of zerumbone and cisplatin to treat cervical intraepithelial neoplasia in female BALB/c mice. Int J Gynecol Cancer 2009;19(6):1004-1010

http://ovidsp.tx.ovid.com.ezp.imu.edu.my/sp 3.10.0b/ovidweb.cgi?

WebLinkFrameset=1&S=GIPIFPAMIPDDPEEINCNKLEJCOPCJAA00&returnUrl=ovidweb.cgi %3f%26Titles%3dS.sh.43%257c1%257c10%26FORMAT%3dtitle%26FIELDS%3dTITLES %26S%3dGIPIFPAMIPDDPEEINCNKLEJCOPCJAA00&directlink=http%3a%2f

%2fgraphics.tx.ovid.com%2fovftpdfs%2fFPDDNCJCLEEIIP00%2ffs047%2fovft%2flive

%2fgv031%2f00009577%2f00009577-200908000-00004.pdf&filename=Combination+of+Zerumbone+and+Cisplatin+to+Treat+Cervical+In traepithelial+Neoplasia+in+Female+BALB

%2fc+Mice.&navigation_links=NavLinks.S.sh.43.1&PDFIdLinkField=%2ffs047%2fovft

%2flive%2fgv031%2f00009577%2f00009577-200908000-00004&link_from=S.sh.43; 1&pdf_key=B&pdf_index=S.sh.43&D=yrovft.

96. Al-Naggar RA, Zaleha MI. Perception and opinion of medical students about Pap smear test: a qualitative study. Asian Pac J Cancer Prev 2010;11(2):435-440

http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No2/435%20Redhwan %20Ahmed%20Al-Naggar.pdf.

97. Alsaad MA, Khadijah S, Fariza F. Knowledge towards HPV infection and HPV vaccines among Syrian mothers. Asian Pac J Cancer Prev 2012;13(3):879-883

http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No3/879-83%202.17%20Mohammed%20Alsaad.pdf.

98. Cheah PL, Looi L, Teoh KH, et al. p16(INK4a) is a useful marker of human papillomavirus integration allowing risk stratification for cervical malignancies. Asian Pac J Cancer Prev 2012;13(2):469-472

(12)

99. Rashwan H, Ishak I, Sawalludin N. Knowledge and views of secondary school students in Kuala Lumpur on cervical cancer and its prevention. Asian Pac J Cancer Prev 2013;14(4):2545-2549.

100. Cheah PL, Looi LM, Ng MH, et al. Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients. J Clin Pathol 2002;55(1):22-26

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1769559/.

101. Farooqui M, Hassali MA, Knight A, et al. A qualitative exploration of Malaysian cancer patients' perceptions of cancer screening. BMC Public Health 2013;13:48-2458-13-48

102. Gravitt PE. Evidence and impact of human papillomavirus latency. Open Virol J 2012;6:198-203

103. Gravitt PE. The known unknowns of HPV natural history. J Clin Invest 2011;121(12):4593-4599

104. Ramasamy S, Abdul Wahab N, Zainal Abidin N, et al. Growth inhibition of human gynecologic and colon cancer cells by Phyllanthus watsonii through apoptosis induction. PLoS One 2012;7(4):e34793

105. Saini R, Khim TP, Rahman SA, et al. High-risk human papillomavirus in the oral cavity of women with cervical cancer, and their children. Virol J 2010;7:131-422X-7-131